Citigroup’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $350K | Buy |
63,959
+10,065
| +19% | +$55.1K | ﹤0.01% | 3113 |
|
|
2025
Q1 | $339K | Buy |
53,894
+6,038
| +13% | +$38K | ﹤0.01% | 3138 |
|
|
2024
Q4 | $197K | Buy |
47,856
+5,232
| +12% | +$21.6K | ﹤0.01% | 3592 |
|
|
2024
Q3 | $142K | Buy |
42,624
+29,637
| +228% | +$99K | ﹤0.01% | 3817 |
|
|
2024
Q2 | $38.7K | Buy |
12,987
+4,284
| +49% | +$12.8K | ﹤0.01% | 3991 |
|
|
2024
Q1 | $30K | Buy |
8,703
+1,747
| +25% | +$6.03K | ﹤0.01% | 4147 |
|
|
2023
Q4 | $9.32K | Buy |
6,956
+6,913
| +16,077% | +$9.26K | ﹤0.01% | 4443 |
|
|
2023
Q3 | $94 | Sell |
43
-12,355
| -100% | -$27K | ﹤0.01% | 4653 |
|
|
2023
Q2 | $29.6K | Buy |
+12,398
| New | +$29.6K | ﹤0.01% | 4175 |
|
|
2022
Q3 | – | Sell |
-1,700
| Closed | -$5K | – | 5404 |
|
|
2022
Q2 | $5K | Buy |
+1,700
| New | +$5K | ﹤0.01% | 4864 |
|